+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Intravenous Infusion Pump Market by Product, by Disease, and by Region - Global Forecast to 2023-2033

  • PDF Icon

    Report

  • 200 Pages
  • January 2023
  • Region: Global
  • Quintana Research and Consulting
  • ID: 5717249
The intravenous infusion pump market size is estimated to be USD 5,452.4 million in 2022 and is expected to witness a CAGR of 8.41% during the forecast period 2023-2033. Rapid expansion of the elderly population and increasing number of surgical procedures are some of the factors projected to drive the market growth in near future. Furthermore, escalating incidences of chronic diseases and growing demand for intravenous pumps are other factors supporting the market growth. However, strict regulatory approval requirements and high price of infusion pumps are predicted to limit market.

Rising incidences of chronic diseases is expected to fuel the market growth during the projected period. For instance, according to the May 2022 update from the Centers for Disease Control and Prevention (CDC), 4 out of 10 adults in the United States have two or more chronic diseases. As patients with chronic diseases are more susceptible to nutrient deficiencies, it is anticipated that the use of IV infusion pumps will rise as chronic disease prevalence increases. In addition, according to the CDC's 2022 report, chronic diseases which account for USD 4.1 trillion in annual healthcare costs in the United States, are the largest source of costs.

Surge in demand for intravenous infusion pumps is predicted to propel the market growth during the forecast period. As the frequency of diseases including diabetes, cancer, and heart conditions is anticipated to increase as a result of faster lifestyle changes, the need for intravenous pumps is also anticipated to experience significant development in the post-pandemic future. ICU Medical also stated that a combination of high demand from current clients and government stockpile orders enhanced demand for their infusion equipment. These factors will increase demand for intravenous infusion pumps throughout the projection period.

Segmentation

By Product

The market is categorized into insulin infusion pumps, volumetric infusion pumps, enteral infusion pumps, ambulatory infusion pumps, syringe infusion pumps, implantable infusion pumps, patient-controlled analgesia (PCA), and others. In 2022, the segment accounted for the highest revenue share due to their ability to continuously deliver highly precise fluid dosages at rates ranging from very slow to very fast. A large market share was contributed in 2022 by ambulatory infusion pumps, which are used to administer liquid nutrients and medications to a patient in both emergencies and chronic diseases. A lot of people prefer using these pumps to administer nourishment and medications. Other pumps like patient-controlled analgesia (PCA) pumps, insulin pumps, and smart pumps will be made available, which would help this market grow further. The growing preference for intravenous infusion pumps, which will also drive market expansion is being fueled by the expanding demand for enteral and syringe pumps.

By Disease

The market is divided into diabetes, chemotherapy, analgesia/pain management, gastroenterology, hematology, pediatrics/neonatology, and others. In the global market, the pediatrics/neonatology segment accounted for the largest revenue share in 2022 owing to significant advancements in pediatric therapy and increasing need for high-quality pediatric care as a result of the increasing number of births worldwide. On the other hand, the hematology segment is anticipated to experience significant growth during the projection period. Hematology has experienced a rise in the demand for intravenous infusion pumps due to an increase in surgical procedures and blood cancer. Blood transfusions are one of the treatments it is used for, and its use is predicted to grow in the upcoming years. Hematology uses intravenous pumps because they are the only means of precise, compact, and continuous blood transfusion into a patient's body. Additionally, it can control human control or in an automated fashion, lowering the risk of treatment failure.

Regional Markets

In 2022, North America region accounted for the highest revenue in the intravenous infusion pump market and is expected to maintain its dominance during the forecast period. This is attributed to rise in the prevalence of chronic diseases, increase in the number of geriatric people, and favourable reimbursement policies in this region. A significant portion of the growth of the regional market is also being driven by the adoption of novel technologically advanced products for routine treatment of chronic disease conditions, knowledge of advanced intravenous infusion pumps, and existence of a well-established healthcare infrastructure. The Asia Pacific market is anticipated to have a high CAGR Over the course of the projected period. Asian nations have dense populations and a high prevalence of chronic diseases including cancer, diabetes, and cardiovascular diseases. These countries are popular locations for medical tourism due to their reputation for affordable healthcare and surgical procedures. Asian growing economies with advanced healthcare facilities and infrastructure include China, Japan, and India.

Competitor Insights

Some of the key players operating in the intravenous infusion pump market are B. Braun Melsungen AG, Medtronic, Terumo Corporation, Micrel Medical Devices SA, Moog Inc., Mindray, Boston Scientific Corporation, CareFusion Corporation, Fresenius Kabi, Smiths Medical, F. Hoffmann-La Roche Ltd., Tandem Diabetes Care, Inc., Baxter International, and Radimed Corporation.

To achieve a competitive edge, these companies are implementing a variety of growth strategies. Strategic partnerships, alliances, and agreements with different businesses and research institutions are seen to be the main strategies used by companies in this sector.

The Novum IQ syringe infusion pump (SYR) with Dose IQ Safety Software, which is one of Baxter's most recent innovations for infusion therapy, was given the FDA's 510(k) approval in August 2022 by Baxter International Inc., a pioneer in cutting-edge technology for medicine administration.

The innovative AutoEx Chemotherapy Infusion Pump that Shanghai MicroPort Lifesciences Co., Ltd. (MicroPort Lifesciences) developed independently was given marketing approval by China's National Medical Products Administration (NMPA) in March 2022. (AutoEx).This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including product and disease from 2022 to 2033.

Segmentation: Intravenous Infusion Pump Market Report 2022 - 2033

Product (Revenue, USD Million), 2022 - 2033

  • Insulin Infusion Pumps
  • Volumetric Infusion Pumps
  • Enteral Infusion Pumps
  • Ambulatory Infusion Pumps
  • Syringe Infusion Pumps
  • Implantable Infusion Pumps
  • Patient Controlled Analgesia (PCA)
  • Others

Disease (Revenue, USD Million), 2022 - 2033

  • Diabetes
  • Chemotherapy
  • Analgesia/Pain Management
  • Gastroenterology
  • Hematology
  • Pediatrics/Neonatology
  • Others

By Region (Revenue, USD Million), 2022 - 2033

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

Middle East & Africa

  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Framework
1.3.1. Research Models
1.3.1.1. Bottom-up Approach
1.3.1.2. Top-down Approach
1.3.1.3. Data Triangulation
1.3.2. Data Analysis
1.3.2.1. Data Validation
1.3.2.2. Market Size Estimation
1.3.2.3. Market Forecast Model

2. Introduction: Intravenous Infusion Pump

3. Executive Summary

4. Market Dynamics
4.1. Market Drivers
4.1.1. Driver 1
4.1.2. Driver 2
4.1.3. Driver 3
4.1.4. Driver 4
4.1.5. Driver 5
4.2. Market Restraint
4.2.1. Restraint 1
4.2.2. Restraint 2
4.2.3. Restraint 3
4.2.4. Restraint 4
4.3. Market Opportunities
4.3.1. Opportunity 1
4.3.2. Opportunity 2
4.3.3. Opportunity 3
4.3.4. Opportunity 4
4.4. Market Trends
4.4.1. Trend 1
4.4.2. Trend 2
4.4.3. Trend 3
4.4.4. Trend 4
4.5. Market Challenges
4.5.1. Challenge 1
4.5.2. Challenge 2
4.5.3. Challenge 3
4.5.4. Challenge 4

5. Market Environment Analysis
5.1. Porter’s 5 Forces Analysis
5.2. PESTEL Analysis
5.3. SWOT Analysis

6. COVID-19 Impact Analysis: Intravenous Infusion Pump Market

7. Market Analysis by Product
7.1. Insulin Infusion Pumps
7.1.1. Insulin Infusion Pumps Market Forecast, 2022-2033 (USD Million)
7.2. Volumetric Infusion Pumps
7.2.1. Volumetric Infusion Pumps Market Forecast, 2022-2033 (USD Million)
7.3. Enteral Infusion Pumps
7.3.1. Enteral Infusion Pumps Market Forecast, 2022-2033 (USD Million)
7.4. Ambulatory Infusion Pumps
7.4.1. Ambulatory Infusion Pumps Market Forecast, 2022-2033 (USD Million)
7.5. Syringe Infusion Pumps
7.5.1. Syringe Infusion Pumps Market Forecast, 2022-2033 (USD Million)
7.6. Implantable Infusion Pumps
7.6.1. Implantable Infusion Pumps Market Forecast, 2022-2033 (USD Million)
7.7. Patient Controlled Analgesia (PCA)
7.7.1. Patient Controlled Analgesia (PCA) Market Forecast, 2022-2033 (USD Million)
7.8. Others
7.8.1. Others Market Forecast, 2022-2033 (USD Million)

8. Market Analysis by End User
8.1. Diabetes
8.1.1. Diabetes Market Forecast, 2022-2033 (USD Million)
8.2. Chemotherapy
8.2.1. Chemotherapy Market Forecast, 2022-2033 (USD Million)
8.3. Analgesia/Pain Management
8.3.1. Analgesia/Pain Management Market Forecast, 2022-2033 (USD Million)
8.4. Gastroenterology
8.4.1. Gastroenterology Market Forecast, 2022-2033 (USD Million)
8.5. Hematology
8.5.1. Hematology Market Forecast, 2022-2033 (USD Million)
8.6. Pediatrics/Neonatology
8.6.1. Pediatrics/Neonatology Market Forecast, 2022-2033 (USD Million)
8.7. Others
8.7.1. Others Market Forecast, 2022-2033 (USD Million)

8. Regional Market Analysis
8.1. Regional Market Trends

9. North America Intravenous Infusion Pump Market
9.1. North America Intravenous Infusion Pump Market
9.1.1. North America Market Size and Forecast, 2022-2033 (USD Million)
9.1.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
9.1.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)
9.2. U.S. Intravenous Infusion Pump Market
9.2.1. U.S. Market Size and Forecast, 2022-2033 (USD Million)
9.2.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
9.2.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)
9.3. Canada Intravenous Infusion Pump Market
9.3.1. Canada Market Size and Forecast, 2022-2033 (USD Million)
9.3.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
9.3.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)

10. Europe Intravenous Infusion Pump Market
10.1. Europe Intravenous Infusion Pump Market
10.1.1. Europe Market Size and Forecast, 2022-2033 (USD Million)
10.1.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
10.1.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)
10.2. Germany Intravenous Infusion Pump Market
10.2.1. Germany Market Size and Forecast, 2022-2033 (USD Million)
10.2.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
10.2.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)
10.3. UK Intravenous Infusion Pump Market
10.3.1. UK Market Size and Forecast, 2022-2033 (USD Million)
10.3.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
10.3.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)
10.4. France Intravenous Infusion Pump Market
10.4.1. France Market Size and Forecast, 2022-2033 (USD Million)
10.4.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
10.4.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)
10.5. Spain Intravenous Infusion Pump Market
10.5.1. Spain Market Size and Forecast, 2022-2033 (USD Million)
10.5.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
10.5.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)
10.6. Italy Intravenous Infusion Pump Market
10.6.1. Italy Market Size and Forecast, 2022-2033 (USD Million)
10.6.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
10.6.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)
10.7. Rest of Europe Intravenous Infusion Pump Market
10.7.1. Rest of Europe Market Size and Forecast, 2022-2033 (USD Million)
10.7.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
10.7.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)

11. Asia Pacific Intravenous Infusion Pump Market
11.1. Asia Pacific Intravenous Infusion Pump Market
11.1.1. Asia Pacific Market Size and Forecast, 2022-2033 (USD Million)
11.1.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.1.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)
11.2. Japan Intravenous Infusion Pump Market
11.2.1. Japan Market Size and Forecast, 2022-2033 (USD Million)
11.2.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.2.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)
11.3. China Intravenous Infusion Pump Market
11.3.1. China Market Size and Forecast, 2022-2033 (USD Million)
11.3.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.3.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)
11.4. India Intravenous Infusion Pump Market
11.4.1. India Market Size and Forecast, 2022-2033 (USD Million)
11.4.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.4.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)
11.5. South Korea Intravenous Infusion Pump Market
11.5.1. South Korea Market Size and Forecast, 2022-2033 (USD Million)
11.5.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.5.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)
11.5.1.3. Market Size and Forecast by Device, 2022-2033 (USD Million)
11.6. Australia Intravenous Infusion Pump Market
11.6.1. Australia Market Size and Forecast, 2022-2033 (USD Million)
11.6.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.6.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)
11.7. Rest of Asia Pacific Intravenous Infusion Pump Market
11.7.1. Rest of Asia Pacific Market Size and Forecast, 2022-2033 (USD Million)
11.7.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.7.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)

12. Latin America Intravenous Infusion Pump Market
12.1. Latin America Intravenous Infusion Pump Market
12.1.1. Latin America Market Size and Forecast, 2022-2033 (USD Million)
12.1.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.1.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)
12.2. Brazil Intravenous Infusion Pump Market
12.2.1. Brazil Market Size and Forecast, 2022-2033 (USD Million)
12.2.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.2.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)
12.3. Mexico Intravenous Infusion Pump Market
12.3.1. Mexico Market Size and Forecast, 2022-2033 (USD Million)
12.3.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.3.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)
12.4. Argentina Intravenous Infusion Pump Market
12.4.1. Argentina Market Size and Forecast, 2022-2033 (USD Million)
12.4.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.4.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)
12.5. Rest of Latin America Intravenous Infusion Pump Market
12.5.1. Rest of Latin America Market Size and Forecast, 2022-2033 (USD Million)
12.5.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.5.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)

13. MEA Intravenous Infusion Pump Market
13.1. MEA Intravenous Infusion Pump Market
13.1.1. MEA Market Size and Forecast, 2022-2033 (USD Million)
13.1.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
13.1.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)
13.2. GCC Intravenous Infusion Pump Market
13.2.1. GCC Market Size and Forecast, 2022-2033 (USD Million)
13.2.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
13.2.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)
13.3. South Africa Intravenous Infusion Pump Market
13.3.1. South Africa Market Size and Forecast, 2022-2033 (USD Million)
13.3.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
13.3.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)
13.4. Rest of MEA Intravenous Infusion Pump Market
13.4.1. Rest of MEA Market Size and Forecast, 2022-2033 (USD Million)
13.4.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
13.4.1.2. Market Size and Forecast by End User, 2022-2033 (USD Million)

14. Competitor Analysis
14.1. Market Share Analysis, 2022
14.2. Major Recent Developments, 2019-2022

15. Company Profiles
15.1. B. Braun Melsungen AG
15.1.1. Company Snapshot
15.1.2. Company Overview
15.1.3. Financials
15.1.4. Product Benchmarking
15.1.5. Recent Developments
15.2. Medtronic
15.2.1. Company Snapshot
15.2.2. Company Overview
15.2.3. Financials
15.2.4. Product Benchmarking
15.2.5. Recent Developments
15.3. Terumo Corporation
15.3.1. Company Snapshot
15.3.2. Company Overview
15.3.3. Financials
15.3.4. Product Benchmarking
15.3.5. Recent Developments
15.4. Micrel Medical Devices SA
15.4.1. Company Snapshot
15.4.2. Company Overview
15.4.3. Financials
15.4.4. Product Benchmarking
15.4.5. Recent Developments
15.5. Moog Inc.
15.5.1. Company Snapshot
15.5.2. Company Overview
15.5.3. Financials
15.5.4. Product Benchmarking
15.5.5. Recent Developments
15.6. Mindray
15.6.1. Company Snapshot
15.6.2. Company Overview
15.6.3. Financials
15.6.4. Product Benchmarking
15.6.5. Recent Developments
15.7. Boston Scientific Corporation
15.7.1. Company Snapshot
15.7.2. Company Overview
15.7.3. Financials
15.7.4. Product Benchmarking
15.7.5. Recent Developments
15.8. CareFusion Corporation
15.8.1. Company Snapshot
15.8.2. Company Overview
15.8.3. Financials
15.8.4. Product Benchmarking
15.8.5. Recent Developments
15.9. Fresenius Kabi
15.9.1. Company Snapshot
15.9.2. Company Overview
15.9.3. Financials
15.9.4. Product Benchmarking
15.9.5. Recent Developments
15.10. Smiths Medical
15.10.1. Company Snapshot
15.10.2. Company Overview
15.10.3. Financials
15.10.4. Product Benchmarking
15.10.5. Recent Developments
15.11. F. Hoffmann-La Roche Ltd.
15.11.1. Company Snapshot
15.11.2. Company Overview
15.11.3. Financials
15.11.4. Product Benchmarking
15.11.5. Recent Developments
15.12. Tandem Diabetes Care, Inc.
15.12.1. Company Snapshot
15.12.2. Company Overview
15.12.3. Financials
15.12.4. Product Benchmarking
15.12.5. Recent Developments
15.13. Baxter International
15.13.1. Company Snapshot
15.13.2. Company Overview
15.13.3. Financials
15.13.4. Product Benchmarking
15.13.5. Recent Developments
15.14. Radimed Corporation
15.14.1. Company Snapshot
15.14.2. Company Overview
15.14.3. Financials
15.14.4. Product Benchmarking
15.14.5. Recent Developments
15.15. Company 15
15.15.1. Company Snapshot
15.15.2. Company Overview
15.15.3. Financials
15.15.4. Product Benchmarking
15.15.5. Recent Developments
15.16. Others Prominent Players

16. Conclusion & Recommendations

Companies Mentioned

A selection of companies mentioned in this report includes:

  • B. Braun Melsungen AG
  • Medtronic
  • Terumo Corporation
  • Micrel Medical Devices SA
  • Moog Inc.
  • Mindray
  • Boston Scientific Corporation
  • CareFusion Corporation
  • Fresenius Kabi
  • Smiths Medical
  • F. Hoffmann-La Roche Ltd.
  • Tandem Diabetes Care Inc.
  • Baxter International
  • Radimed Corporation.